Departments of Endocrinology, Metabolism and Diabetes, D02:04, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
Eur J Endocrinol. 2012 Mar;166(3):441-9. doi: 10.1530/EJE-11-0828. Epub 2011 Dec 9.
Fertility in males with congenital adrenal hyperplasia (CAH) is reported from normal to severely impaired. Therefore, we investigated fertility/fecundity, social/sexual situation, and pituitary-gonadal function in CAH males.
The patient cohort comprised 30 males, aged 19-67 years, with 21-hydroxylase deficiency. Their fertility was compared with age-matched national population data. For the evaluation of social/sexual factors and hormone status, age-matched controls were recruited (n = 32). Subgroups of different ages (<30 years and older) and CYP21A2 genotypes (null (severe salt-wasting (SW)), I2splice (milder SW), and I172N (simple virilizing)) were also studied. Patients underwent testicular ultrasound examination (n = 21) and semen analysis (n = 14).
Fertility was impaired in CAH males compared with national data (0.9 ± 1.3 vs 1.8 ± 0.5 children/father, P<0.001). There were no major differences in social and sexual factors between patients and controls apart from more fecundity problems, particularly in the I172N group. The patients had lower testosterone/estradiol (E(2)) ratio and inhibin B, and higher FSH. The semen samples were pathological in 43% (6/14) of patients and sperm concentration correlated with inhibin B and FSH. Testicular adrenal rest tumors (TARTs) were found in 86% (18/21). Functional testicular volume correlated positively with the testosterone/E(2) ratio, sperm concentration, and inhibin B. Patients with pathological semen had increased fat mass and indications of increased cardiometabolic risk.
Fertility/fecundity was impaired in CAH males. The frequent occurrence of TARTs resulting in testicular insufficiency appears to be the major cause, but other factors such as elevated fat mass may contribute to a low semen quality.
男性先天性肾上腺皮质增生症(CAH)患者的生育力报告从正常到严重受损不等。因此,我们调查了 CAH 男性的生育力/生育能力、社会/性生活状况和垂体-性腺功能。
患者队列包括 30 名年龄在 19-67 岁之间的 21-羟化酶缺乏症男性患者。将他们的生育能力与年龄匹配的全国人口数据进行比较。为了评估社会/性生活因素和激素状态,招募了年龄匹配的对照组(n=32)。还研究了不同年龄(<30 岁和>30 岁)和 CYP21A2 基因型(null(严重盐耗竭(SW))、I2splice(较轻的 SW)和 I172N(单纯性男性化))的亚组。患者接受了睾丸超声检查(n=21)和精液分析(n=14)。
与全国数据相比,CAH 男性的生育力受损(0.9±1.3 与 1.8±0.5 个孩子/父亲,P<0.001)。除了生育力问题更多,特别是在 I172N 组,患者和对照组在社会和性生活方面没有重大差异。与对照组相比,患者的睾酮/雌二醇(E2)比值和抑制素 B 较低,FSH 较高。在 43%(6/14)的患者中,精液样本存在病理性,精子浓度与抑制素 B 和 FSH 相关。86%(18/21)的患者发现睾丸肾上腺残余肿瘤(TART)。功能性睾丸体积与睾酮/E2 比值、精子浓度和抑制素 B 呈正相关。精液检查异常的患者体脂增加,表明存在代谢风险增加的迹象。
CAH 男性的生育力/生育能力受损。导致睾丸功能不全的 TART 频繁发生似乎是主要原因,但其他因素,如体脂增加,可能导致精液质量下降。